Most cited papers from Biocartis (Belgium)

Biocartis (Belgium)

What are the most cited papers from Biocartis (Belgium)?

The most cited paper from Biocartis (Belgium) is "Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors" (Max S. Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al., 2016), with 141 citations. Next come "Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream Infections" (88) and "BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System" (78).

Published TypeFieldAccess

Showing 50 of 52 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors Max S. Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al. · Journal of Translational Medicine Open access	19 Apr 2016	141
2	Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream Infections Anne J. M. Loonen, Martine P. Bos, Bart Van Meerbergen et al. · PLoS ONE Open access	15 Aug 2013	88
3	BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System Filip Jankú et al. · Molecular Cancer Therapeutics	22 May 2016	78
4	BRAF mutation testing with a rapid, fully integrated molecular diagnostics system Filip Jankú et al. · Oncotarget Open access	27 Jul 2015	51
5	Multi-center evaluation of the novel fully-automated PCR-based Idylla™ BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma Linea Cecilie Melchior, Morten Grauslund, Beatríz Bellosillo et al. · Experimental and Molecular Pathology	26 Sep 2015	48
6	Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer Jérôme Solassol et al. · PLoS ONE Open access	29 Sep 2016	37
7	Structure‐Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties Maxwell D. Cummings et al. · Angewandte Chemie International Edition	30 Mar 2012	37
8	Adaptation and standardization of a Western tool for assessing child development in non-Western low-income context Teklu Gemechu Abessa, Berhanu Nigussie Worku, Mekitie Wondafrash Kibebew et al. · BMC Public Health Open access	27 Jul 2016	33
9	Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti–Epidermal Growth Factor Receptor Therapy Joan Maurel et al. · JCO Precision Oncology	18 Apr 2019	27
10	Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue Louise Johnston, Michael Power, Philip Sloan et al. · Journal of Clinical Pathology Open access	12 Sep 2017	21
11	Development and Performance of Conventional HIV-1 Phenotyping (Antivirogram®) and Genotype-Based Calculated Phenotyping Assay (virco®TYPE HIV-1) on Protease and Reverse Transcriptase Genes to Evaluate Drug Resistance Theresa Pattery, Yvan Verlinden, Hans Wolf et al. · Intervirology Open access	2012	21
12	Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanoma Max S. Schreuer, Geert Meersseman, Sari Van Den Herrewegen et al. · Melanoma Research	3 Dec 2015	19
13	Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis Laure Sorber, Bart Claes, Karen Zwaenepoel et al. · American Journal of Clinical Pathology Open access	24 Jun 2021	18
14	The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe Victoria Wurcel, Olivier Perche, Daniel Lesteven et al. · Public Health Genomics Open access	2016	18
15	Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice James L. Sherwood, Helen J. Brown, Alessandro Rettino et al. · ESMO Open Open access	2017	17
16	NTRK Gene Fusion Detection in a Pan-Cancer Setting Using the Idylla GeneFusion Assay Laure Sorber, Bieke Van Dorst, Ellen Bellon et al. · Journal of Molecular Diagnostics Open access	9 May 2022	15
17	Expression and Purification of Dengue Virus NS5 Polymerase and Development of a High-Throughput Enzymatic Assay for Screening Inhibitors of Dengue Polymerase Edwin Yunhao Gong, Hannah Kenens, Tania Ivens et al. · Methods in molecular biology Book chapter	2013	15
18	Performance of a Multiplex Serological Helicobacter pylori Assay on a Novel Microfluidic Assay Platform Angela Filomena, Anna Guenther, Hannes Planatscher et al. · Proteomes Open access	3 Oct 2017	14
19	Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform Lieselotte Cnops, Peter Van den Eede, James Pettitt et al. · The Journal of Infectious Diseases Open access	30 May 2016	14
20	Assessment of a molecular diagnostic platform for integrated isolation and quantification of mRNA in whole blood Corné H. van den Kieboom, Gerben Ferwerda, Inky De Baere et al. · European Journal of Clinical Microbiology & Infectious Diseases Open access	22 Aug 2015	9
21	A Duplex Real-Time RT-PCR Assay for Profiling Inhibitors of Four Dengue Serotypes Edwin Yunhao Gong, Alexandra Smets, Nick Verheyen et al. · Methods in molecular biology Book chapter	2013	8
22	Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens Debby Thomas, Doreen Dillaerts, Maaike Cockx et al. · Journal of Immunological Methods Open access	4 Mar 2022	6
23	Development of a High-Throughput Antiviral Assay for Screening Inhibitors of Chikungunya Virus and Generation of Drug-Resistant Mutations in Cultured Cells Edwin Yunhao Gong, Jean‐François Bonfanti, Tania Ivens et al. · Methods in molecular biology Book chapter	2013	5
24	Cell-Based Antiviral Assays for Screening and Profiling Inhibitors Against Dengue Virus Edwin Yunhao Gong, Marleen Clynhens, Tania Ivens et al. · Methods in molecular biology Book chapter	2013	5
25	Characterization and Clinical Utility of BRAFV600 Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma Piotr Lukasz Rutkowski, Patrick Pauwels, Joseph N. Kerger et al. · Cancers Open access	17 Jul 2021	4
26	Detection of microsatellite instability (MSI) with a novel set of 7 Idylla biomarkers on colorectal cancer samples in a multi-center study Bram De Craene, Jan Van de Velde, Ellen Bellon et al. · Annals of Oncology Open access	Oct 2018	4
27	Detection of microsatellite instability (MSI) in colorectal cancer samples with the automated Idylla MSI Test Geert G. Maertens, Bram De Craene, Evelien Rondelez et al. · Annals of Oncology Open access	Sep 2017	4
28	Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells Kris Covens, Bert Verbinnen, Britt G. de Jong et al. · Frontiers in Immunology Open access	10 Jul 2023	3
29	Detection of microsatellite instability (MSI) with a novel panel of biomarkers in gastric cancer samples Bram De Craene, Zhu Feng, Evelien Rondelez et al. · Annals of Oncology Open access	Sep 2017	3
30	A Fluorescence-Based High-Throughput Screening Assay to Identify HIV-1 Inhibitors Peggy Geluykens, Koen Van Acker, Johan Vingerhoets et al. · Methods in molecular biology Book chapter	2013	3
31	MyCartis NV Wouter Laroy, Paul Ladestein · Biomarkers in Medicine	Feb 2015	2
32	Feasibility study of a ctEGFR prototype assay on the fully automated Idylla™ platform Martin Reijans, Sofie Van Gestel, E. De Haes et al. · Annals of Oncology Open access	Oct 2019	2
33	Fully automated and sensitive detection of EGFR exon 18, 19, 20 and 21 mutational status in less than 2.5 hours from a single FFPE slice Martin Reijans, Geneviève Vandercruyssen, Inge Keuleers et al. · Annals of Oncology Open access	Oct 2016	2
34	Identification of HIV-1 Reverse Transcriptase Inhibitors Using a Scintillation Proximity Assay Bertrand Van Schoubroeck, Marnix Van Loock, Tania Ivens et al. · Methods in molecular biology Book chapter	2013	2
35	Development of a rapid and fully automated Idylla™ assay for qualitative detection of mutations in the PIK3CA and AKT1 gene in advanced breast cancer FFPE samples T. Piofczyk, K. Covens, Tom Adriany et al. · European Journal of Cancer Open access	Oct 2022	1
36	Surface Plasmon Resonance as a Tool to Select Potent Drug Candidates for Hepatitis C Virus NS5B Polymerase Erna Cleiren, Benoit Devogelaere, Katleen Fierens · Methods in molecular biology Book chapter	2013	1
37	Biochemical Screening Assays to Identify HIV-1 Integrase Inhibitors Marleen Clynhens, Alexandra Smets, Inge Vereycken et al. · Methods in molecular biology Book chapter	2013	1
38	The Cost of Molecular Diagnostic Testing in Oncology – a Workflow Analysis Beatríz Bellosillo, Jean-Claude Pages, Christine Collin et al. · Value in Health Open access	20 Oct 2015	1
39	Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-Based PCR Assay Gloria Hopkins Sura, Srividya Arjuna, Mohamed H. Maher et al. · Journal of Molecular Diagnostics Open access	19 Jun 2026	0
40	582eP Performance evaluation of the Idylla™ PIK3CA-AKT1 mutation assay in an independent pan-cancer cohort K. Broos, S. De Smedt, A. D'Hoore et al. · ESMO Open Open access	May 2026	0
41	Multicenter evaluation of the Idylla IDH1-2 Mutation Assay Kit for detection of IDH mutational status in glioma Michael Jansen et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin Open access	13 Mar 2026	0
42	Rapid Increase in Blood CD19 CAR-T Vector Load during the First 5 Days Post Infusion Is Associated with Severe Icans Sushma Bharadwaj et al. · Transplantation and Cellular Therapy Open access	Feb 2025	0
43	Real Time, Point-of-Need Measurement of Blood CD19 CAR-T Vector Load Is Concordant with Standard Ddpcr Method Sushma Bharadwaj et al. · Transplantation and Cellular Therapy Open access	Feb 2024	0
44	A single arm, open label, phase II, multicenter study to assess the detection of the BRAF V600 mutation on cfDNA from plasma in patients with advanced melanoma Piotr Lukasz Rutkowski, Patrick Pauwels, Joseph N. Kerger et al. · Annals of Oncology Open access	Oct 2019	0
45	Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials Clara O. Montagut, Vicente Alonso, Pilar Escudero et al. · Annals of Oncology Open access	Oct 2018	0
46	A Near Point of Care Test for Interleukin 1B During Human Ex-Vivo Lung Perfusion Anders Andreasson, Wouter Laroy, John Henry Dark et al. · The Journal of Heart and Lung Transplantation	30 Mar 2018	0
47	Implications of key differences across 12 KRAS mutation detection technologies and their relevance in clinical practice James L. Sherwood, Alessandro Rettino, C. Hendricks Brown et al. · Annals of Oncology Open access	Oct 2016	0
48	Ultra-rapid, sensitive, and fully automated extended RAS testing for metastatic colorectal cancer – evaluation of an NRAS/BRAF/EGFR492 module Ellen Vercauteren, Ellen Bellon, Katrien Vermeiren et al. · Annals of Oncology Open access	Oct 2016	0
49	P1‐197: EvalutionTM, A Novel Multiplex Technology for Simultaneous Quantification of Inflammation Markers, β‐Amyloid and TAU Proteins Joseph K. She, Nathalie Van Landuyt, Leentje Demeyer et al. · Alzheimer s & Dementia	Jul 2016	0
50	Fully automated diagnosis of MERS-CoV infection in respiratory specimen on the IdyllaTM MDx Platform Nicholas M. Trost, Arnaud Gilles, Ignacio Erquiaga et al. · Journal of Clinical Virology Open access	Sep 2016	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.